Heterologous production of plant-derived isoprenoid products in microbes and the application of metabolic engineering and synthetic biology

Ajikumar, 2010, Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli, Science, 330, 70, 10.1126/science.1191652 Paddon, 2013, High-level semi-synthetic production of the potent antimalarial artemisinin, Nature, 496, 528, 10.1038/nature12051 Raskin, 2002, Plants and human health in the twenty-first century, Trends Biotechnol, 20, 522, 10.1016/S0167-7799(02)02080-2 Itokawa, 2008, Plant-derived natural product research aimed at new drug discovery, J Nat Med, 62, 263, 10.1007/s11418-008-0246-z Patil, 2013, Cellular aggregation is a key parameter associated with long term variability in paclitaxel accumulation in Taxus suspension cultures, Plant Cell Tissue Organ Cult, 112, 303, 10.1007/s11240-012-0237-3 Smetanska, 2008, Production of secondary metabolites using plant cell cultures, Adv Biochem Eng Biotechnol, 111, 187 Mitchell, 2011, Natural products from synthetic biology, Curr Opin Chem Biol, 15, 505, 10.1016/j.cbpa.2011.05.017 Keasling, 2012, Synthetic biology and the development of tools for metabolic engineering, Metab Eng, 14, 189, 10.1016/j.ymben.2012.01.004 Wilson, 2012, Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules, Plant Biotechnol J, 10, 249, 10.1111/j.1467-7652.2011.00664.x Danishefsky, 1996, Total synthesis of baccatin III and taxol, J Am Chem Soc, 118, 2843, 10.1021/ja952692a Baloglu, 1999, A new semisynthesis of paclitaxel from baccatin III, J Nat Prod, 62, 1068, 10.1021/np990040k Ongley, 2013, Recent advances in the heterologous expression of microbial natural product biosynthetic pathways, Nat Prod Rep, 30, 1121, 10.1039/c3np70034h Zhang, 2011, Methods and options for the heterologous production of complex natural products, Nat Prod Rep, 28, 125, 10.1039/C0NP00037J Misawa, 1990, Elucidation of the Erwinia uredovora carotenoid biosynthetic pathway by functional analysis of gene products expressed in Escherichia coli, J Bacteriol, 172, 6704, 10.1128/jb.172.12.6704-6712.1990 Yamano, 1994, Metabolic engineering for production of beta-carotene and lycopene in Saccharomyces cerevisiae, Biosci Biotechnol Biochem, 58, 1112, 10.1271/bbb.58.1112 Shimada, 1998, Increased carotenoid production by the food yeast Candida utilis through metabolic engineering of the isoprenoid pathway, Appl Environ Microbiol, 64, 2676, 10.1128/AEM.64.7.2676-2680.1998 Harker, 1999, Expression of prokaryotic 1-deoxy-d-xylulose-5-phosphatases in Escherichia coli increases carotenoid and ubiquinone biosynthesis, FEBS Lett, 448, 115, 10.1016/S0014-5793(99)00360-9 Wang, 2000, Directed evolution of metabolically engineered Escherichia coli for carotenoid production, Biotechnol Prog, 16, 922, 10.1021/bp000124f Farmer, 2001, Precursor balancing for metabolic engineering of lycopene production in Escherichia coli, Biotechnol Prog, 17, 57, 10.1021/bp000137t Alper, 2005, Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets, Nat Biotech, 23, 612, 10.1038/nbt1083 Jin, 2007, Multi-dimensional gene target search for improving lycopene biosynthesis in Escherichia coli, Metab Eng, 9, 337, 10.1016/j.ymben.2007.03.003 Wang, 2009, Programming cells by multiplex genome engineering and accelerated evolution, Nature, 460, 894, 10.1038/nature08187 Tyo, 2009, Stabilized gene duplication enables long-term selection-free heterologous pathway expression, Nat Biotechnol, 27, 760, 10.1038/nbt.1555 Choi, 2010, In silico identification of gene amplification targets for improvement of lycopene production, Appl Environ Microbiol, 76, 3097, 10.1128/AEM.00115-10 Chen, 2013, Chromosomal evolution of Escherichia coli for the efficient production of lycopene, BMC Biotechnol, 13, 1472, 10.1186/1472-6750-13-6 Zhang, 2013, Combining genotype improvement and statistical media optimization for isoprenoid production in E. coli, PLoS ONE, 8, 0075164, 10.1371/journal.pone.0075164 Martin, 2003, Engineering a mevalonate pathway in Escherichia coli for production of terpenoids, Nat Biotech, 21, 796, 10.1038/nbt833 Lindahl, 2006, Production of the artemisinin precursor amorpha-4,11-diene by engineered Saccharomyces cerevisiae, Biotechnol Lett, 28, 571, 10.1007/s10529-006-0015-6 Ro, 2006, Production of the antimalarial drug precursor artemisinic acid in engineered yeast, Nature, 440, 940, 10.1038/nature04640 Newman, 2006, High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli, Biotechnol Bioeng, 95, 684, 10.1002/bit.21017 Pitera, 2007, Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli, Metab Eng, 9, 193, 10.1016/j.ymben.2006.11.002 Komatsu, 2010, Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism, Proc Natl Acad Sci U S A, 107, 2646, 10.1073/pnas.0914833107 Farhi, 2011, Harnessing yeast subcellular compartments for the production of plant terpenoids, Metab Eng, 13, 474, 10.1016/j.ymben.2011.05.001 Zhou, 2013, Optimization of amorphadiene synthesis in Bacillus subtilis via transcriptional, translational, and media modulation, Biotechnol Bioeng, 110, 2556, 10.1002/bit.24900 Huang, 2001, Engineering Escherichia coli for the synthesis of taxadiene, a key intermediate in the biosynthesis of taxol, Bioorg Med Chem, 9, 2237, 10.1016/S0968-0896(01)00072-4 DeJong, 2006, Genetic engineering of Taxol biosynthetic genes in Saccharomyces cerevisiae, Biotechnol Bioeng, 93, 212, 10.1002/bit.20694 Engels, 2008, Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production, Metab Eng, 10, 201, 10.1016/j.ymben.2008.03.001 Carr, 2009, Genome engineering, Nat Biotechnol, 27, 1151, 10.1038/nbt.1590 Fuller, 2009, The challenges of sequencing by synthesis, Nat Biotechnol, 27, 1013, 10.1038/nbt.1585 Patti, 2012, Innovation: metabolomics: the apogee of the omics trilogy, Nat Rev Mol Cell Biol, 13, 263, 10.1038/nrm3314 Kaltashov, 2012, Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics, Biotechnol Adv, 30, 210, 10.1016/j.biotechadv.2011.05.006 Blazeck, 2013, Promoter engineering: recent advances in controlling transcription at the most fundamental level, Biotechnol J, 8, 46, 10.1002/biot.201200120 Wang, 2012, Genome-scale promoter engineering by coselection MAGE, Nat Methods, 9, 591, 10.1038/nmeth.1971 Enyeart, 2011, Synthetic biology: a yeast for all reasons, Nature, 477, 413, 10.1038/477413a Pfeifer, 2001, Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli, Science, 291, 1790, 10.1126/science.1058092 Woolston, 2013, Metabolic engineering: past and future, Annu Rev Chem Biomol Eng, 4, 259, 10.1146/annurev-chembioeng-061312-103312 Prather, 2008, De novo biosynthetic pathways: rational design of microbial chemical factories, Curr Opin Biotechnol, 19, 468, 10.1016/j.copbio.2008.07.009 Dietrich, 2009, A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3), ACS Chem Biol, 4, 261, 10.1021/cb900006h Dai, 2013, Metabolic engineering of Saccharomyces cerevisiae for production of ginsenosides, Metab Eng, 11, 146, 10.1016/j.ymben.2013.10.004 Gibson, 2010, Creation of a bacterial cell controlled by a chemically synthesized genome, Science, 329, 52, 10.1126/science.1190719